OSE Immunotherapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 257,926 | 1.19% |
| Private Companies | 788,700 | 3.63% |
| Individual Insiders | 4,634,098 | 21.3% |
| General Public | 16,072,557 | 73.9% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 2,007,163 | €17.6m | 0% | no data | |||
| 1,860,049 | €16.3m | 0% | no data | |||
| 788,700 | €6.9m | 0% | no data | |||
| 424,084 | €3.7m | 0% | no data | |||
| 342,802 | €3.0m | 0% | no data | |||
| 135,000 | €1.2m | 0% | 0.13% | |||
| 110,000 | €966.9k | 0% | 0.33% | |||
| 106,900 | €939.7k | 0% | 2.77% | |||
| 6,766 | €59.5k | 0% | 0.01% | |||
| 1,500 | €13.2k | 0% | 0.54% |